Pentraxin Therapeutics Overview

  • Founded
  • 2001
Founded
  • Status
  • Private
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $7M
Latest Deal Amount
  • Investors
  • 4

Pentraxin Therapeutics General Information

Description

Developer of drugs research platform intended to offer treatment of amyloidosis and amyloid-related diseases. The company's platform designs and develops new treatments for systemic amyloidosis and amyloid-related diseases, Alzheimer's disease and type II diabetes and targeting the pathogenic effects of C-reactive protein in cardiovascular and inflammatory diseases, enabling doctors to cure amyloid-related diseases and to speed up patients' access to new medicines.

Contact Information

Formerly Known As
Hallco 646
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • C/O UCL Business PLC The Network Building
  • 97 Tottenham Court Road
  • London W1T 4TP
  • England, United Kingdom
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Pentraxin Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 29-Sep-2008 $7M Completed Generating Revenue
1. Early Stage VC Completed Startup
To view Pentraxin Therapeutics’s complete valuation and funding history, request access »

Pentraxin Therapeutics Executive Team (1)

Name Title Board Seat Contact Info
Mark Pepys Ph.D Founder, Head of Medicine & Director
To view Pentraxin Therapeutics’s complete executive team members history, request access »

Pentraxin Therapeutics Board Members (4)

Name Representing Role Since
Cengiz Tarhan UCL Business Director 000 0000
Mark Pepys Ph.D Pentraxin Therapeutics Founder, Head of Medicine & Director 000 0000
Philip Hawkins Ph.D Pentraxin Therapeutics Director 000 0000
Stephen Wood Pentraxin Therapeutics Director 000 0000
To view Pentraxin Therapeutics’s complete board members history, request access »

Pentraxin Therapeutics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Wellcome Trust Limited Partner 000 0000 000000 0
Philip Hawkins Angel (individual) Minority 000 0000 000000 0
Stephen Wood Angel (individual) Minority 000 0000 000000 0
UCL Business Not-For-Profit Venture Capital Minority 000 0000 000000 0
To view Pentraxin Therapeutics’s complete investors history, request access »